INHIBITION OF ANGIOGENESIS IN BREAST CANCER USING AN EFFECTIVE NANOCARRIER:
Breast Cancer is one of the leading causes of death in women population and the art of angiogenesis makes the pathological condition even more worser underneath. We are now working on to prepare a very effective nanocarrier which can carry the angiogenesis inhibitor and successfully down-regulate the signaling system behind the angiogenesis. The result would be to stop the vasculature of cancer tissue mass and make them starve for nutrients and oxygen supply leading to their death.
Seminars and Presentations
PUBLICATIONS
- Zebrafish in angiogenic research – an expanding role: A review (to be submitted).
Srivani Veeranarayanan, T. Maekawa, Y. Yoshida, D. Sakthi Kumar.
SEMINARS PRESENTATION
- Nanoparticle mediated Angiogenesis inhibitor delivery to suppress tumor vasculature in Breast cancer. (Abstract submitted) - Poster.
Srivani Veeranarayanan, T. Maekawa, Y. Yoshida, D. Sakthi Kumar.
7th International Symposium on Bioscience and Nanotechnology, Tokyo, Japan, 20 -21 November 2009.
- Breast cancer angiogenesis as therapeutic target – A Review.
Srivani Veeranarayanan
Departmental presentation -2nd July, 2009.